Analysis of the ESC/EACTS 2020 atrial fibrillation guidelines with perioperative implications
JA Nelson, YX Gue, JM Christensen, GYH Lip… - … of Cardiothoracic and …, 2022 - Elsevier
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide, with an
individual lifetime risk of approximately 37% in the United States. Broadly defined as a …
individual lifetime risk of approximately 37% in the United States. Broadly defined as a …
[HTML][HTML] Periprocedural bridging anticoagulation in patients with venous thromboembolism: a registry‐based cohort study
GD Barnes, Y Li, X Gu, B Haymart… - Journal of thrombosis …, 2020 - Elsevier
Background Use of bridging anticoagulation increases a patient's bleeding risk without clear
evidence of thrombotic prevention among warfarin‐treated patients with atrial fibrillation …
evidence of thrombotic prevention among warfarin‐treated patients with atrial fibrillation …
[PDF][PDF] Perioperativ heparinbridging er sjældent indiceret
JD Nielsen, TS Hermann, D Husum… - Ugeskr Læger, 2021 - content.ugeskriftet.dk
Når patienter, som er i behandling med en vitamin K-antagonist (VKA), skal opereres eller
have foretaget anden invasiv procedure, der kræver pausering af VKA-behandling, har de …
have foretaget anden invasiv procedure, der kræver pausering af VKA-behandling, har de …
Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thromboembolic events in general and visceral surgery
I Döhler, D Röder, T Schlesinger, CA Nassen… - BMC …, 2023 - Springer
Background Perioperative bridging of oral anticoagulation increases the risk of bleeding
complications after elective general and visceral surgery. The aim of this study was to …
complications after elective general and visceral surgery. The aim of this study was to …